Fresenius Kabi
Products for chronically and critically ill patients
Fresenius Helios
Europe’s leading private healthcare provider
Archive "Stories"
Contact
Nick Stone Senior Vice President Investor Relations Head of Investor Relations
ir-fre@fresenius.com
Anke Schmidt Chief Communications Officer T +49 (0) 6172 686 495
anke.schmidt@fresenius.com
Share
Facebook
Twitter
LinkedIn
Xing
E-Mail
Services
Print
RSS
October 07, 2024 | Geneva, Switzerland
October 02, 2024 | Paris, France
September 03, 2024 | Chicago, USA
August 29, 2024 | Netherlands
August 28, 2024 | Brussels, Belgium
August 01, 2024 | London, UK
May 09, 2024 | London, UK
March 06, 2024 | Boston, USA
March 05, 2024 | New York, USA
February 26, 2024 | Frankfurt, Germany